Standardization and comparison of nonautomated assays to measure the collagen binding activity of von Willebrand factor.

L M M OliveiraM V A AmorimC A CorsiniC C A NetoDaniel Gonçalves Chaves

Published in: International journal of laboratory hematology (2018)

The ELISA test demonstrated better performance to detect VWF-collagen binding activity in healthy individuals and VWD patients. This test could differentiate 2A and 2M subtypes using a feasible protocol that can be easily implemented.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
randomized controlled trial
prognostic factors
peritoneal dialysis
high throughput
binding protein
patient reported outcomes
transcription factor
clinical evaluation